GlassScriptPhysician profile
Namee C Kim
NPI 1164745725
$6,169.73
in general payments reported to CMS, 2019-2025
36 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,542 · 2020: $623 · 2021: $301 · 2022: $577 · 2023: $1,268 · 2024: $858 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,126.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $627.57 | 2019-2025 | |
| Medtronic, INC. | $613.79 | 2021-2025 | Linq II, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $517.77 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $491.88 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Pfizer INC. | $474.67 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $441.41 | 2019-2024 | Eliquis, Camzyos |
| Amgen INC. | $267.33 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $263.60 | 2019-2020 | |
| Philips North America LLC | $248.76 | 2020-2024 | (5044) Mcot, (Ck4) Mcot |
| Braemar Manufacturing, LLC | $233.96 | 2019 | |
| Abbott Laboratories | $225.96 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.94 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $151.04 | 2019-2025 | Farxiga |
| Lantheus Medical Imaging, INC. | $149.56 | 2019-2024 | Definity |
| Cvrx, INC. | $142.18 | 2023-2025 | Barostim Neo System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $129.87 | 2019-2023 | |
| Biotronik INC. | $126.54 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.84 | 2024-2025 | Jardiance |
| Esperion Therapeutics, INC. | $97.80 | 2023-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $79.36 | 2025 | Amvuttra |
| Amarin Pharma, INC. | $68.67 | 2019-2020 | |
| Irhythm Technologies, INC. | $65.02 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $61.87 | 2023-2024 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals, LTD. | $58.76 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $38.48 | 2019-2023 | Evkeeza |
| Baxter Healthcare | $35.46 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Astellas Pharma US INC | $35.07 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $33.49 | 2024 | Arcalyst |
| Medicomp INC | $31.66 | 2023 | Telepatch Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $28.22 | 2024 | Assure Wcd |
| Gilead Sciences, INC. | $23.78 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $21.13 | 2023 | Inpefa |
| Lundbeck LLC | $19.79 | 2019 | |
| Merck Sharp & Dohme LLC | $19.77 | 2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $17.90 | 2019 | |
| Travere Therapeutics, INC. | $0.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Namee Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.